ArticleFrontiers in oncology2019

Mechanism of Action and Clinical Efficacy of CDK4/6 Inhibitors in BRCA-Mutated, Estrogen Receptor-Positive Breast Cancers: Case Report and Literature Review.

Anna Maria Militello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.